Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.72% is 54% above its 5-year average of 1.11%, near the low end of its 5-year range (0.00%–24.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 93.52% above its 12-month average of 0.89%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.72%.
DEBT TO ASSETS RATIO
1.72%
DEBT TO ASSETS RATIO AVG TTM
0.89%
DEBT TO ASSETS RATIO AVG 3Y
0.84%
DEBT TO ASSETS RATIO AVG 5Y
1.11%
DEBT TO ASSETS RATIO AVG 10Y
1.33%
DEBT TO ASSETS RATIO AVG 15Y
1.01%
DEBT TO ASSETS RATIO AVG 20Y
1.66%
CURRENT VS TTM AVG
+93.52%
CURRENT VS 3Y AVG
+103.08%
CURRENT VS 5Y AVG
+54.46%
CURRENT VS 10Y AVG
+28.91%
CURRENT VS 15Y AVG
+69.46%
CURRENT VS 20Y AVG
+3.49%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+1805.99%
vs the sector median at left
Gyre Therapeutics, Inc.
Market Cap
$789.34M
Debt to Assets Ratio
1.72%
TTM Avg
0.89%
3Y Avg
0.84%
5Y Avg
1.11%
Market Cap
$778.01M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$777.34M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$765.30M
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$816.13M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$761.37M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | $789.34M | 1.72% | 0.89% | 0.84% | 1.11% |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | 0.48% | N/A | N/A | N/A |
| Varex Imaging Corporation (VREX)vs › | $778.01M | 0.34% | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | 0.24% | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $776.24M | 0.24% | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $804.16M | 0.01% | N/A | N/A | N/A |
| Sana Biotechnology, Inc. (SANA)vs › | $765.30M | 0.17% | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $816.13M | 0.00% | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 0.24% | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | 0.44% | N/A | N/A | N/A |
Debt/Assets
1.7%
Debt/Equity
0.03
Current Ratio
4.26
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.72% |
| 2026-03-31 | 0.51% |
| 2025-12-31 | 0.57% |
| 2025-09-30 | 0.73% |
| 2025-06-30 | 0.91% |
| 2025-03-31 | 1.22% |
| 2024-12-31 | 1.27% |
| 2024-09-30 | 1.43% |
| 2024-06-30 | 1.62% |
| 2024-03-31 | 0.23% |
| 2023-12-31 | 0.35% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.43% |
| 2023-03-31 | 24.27% |
| 2022-12-31 | 0.72% |
| 2022-09-30 | 0.72% |
| 2022-06-30 | 1.70% |
| 2022-03-31 | 4.74% |
| 2021-12-31 | 4.28% |
| 2021-09-30 | 3.05% |
| 2021-06-30 | 2.82% |
| 2021-03-31 | 1.25% |
| 2020-12-31 | 1.73% |
| 2020-09-30 | 1.29% |
| 2020-06-30 | 1.27% |
| 2020-03-31 | 1.52% |
| 2019-12-31 | 1.83% |
| 2019-09-30 | 2.09% |
| 2019-06-30 | 2.01% |
| 2019-03-31 | 1.91% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 12.87% |
| 2017-09-30 | 15.96% |
| 2017-06-30 | 14.56% |
| 2017-03-31 | 43.53% |
| 2016-12-31 | 50.94% |
| 2016-09-30 | 57.48% |
| 2016-06-30 | 53.03% |
| 2016-03-31 | 50.27% |
| 2015-12-31 | 48.54% |
| 2015-09-30 | 46.67% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.41% |
| 2014-06-30 | 0.56% |
| 2014-03-31 | 0.68% |
| 2013-12-31 | 0.78% |
| 2013-09-30 | 0.86% |
| 2013-06-30 | 0.93% |
| 2013-03-31 | 0.99% |
| 2012-12-31 | 1.05% |
| 2012-09-30 | 1.08% |
| 2012-06-30 | 1.14% |
| 2012-03-31 | 1.16% |
| 2011-12-31 | 1.25% |
| 2011-09-30 | 1.35% |
| 2011-06-30 | 1.45% |
| 2011-03-31 | 1.10% |
| 2010-12-31 | 1.16% |
| 2010-09-30 | 1.28% |
| 2010-06-30 | 0.92% |
| 2010-03-31 | 1.04% |
| 2009-12-31 | 1.07% |
| 2009-09-30 | 4.48% |
| 2009-06-30 | 5.00% |
| 2009-03-31 | 4.86% |
| 2008-12-31 | 4.87% |
| 2008-09-30 | 4.91% |
| 2008-06-30 | 4.44% |
| 2008-03-31 | 4.49% |
| 2007-12-31 | 2.63% |
| 2007-09-30 | 2.94% |
| 2007-06-30 | 4.47% |
| 2007-03-31 | 1.73% |
| 2006-12-31 | 1.73% |
| 2006-09-30 | 2.40% |
| 2006-06-30 | 2.89% |
| 2006-03-31 | 6.02% |
| 2005-12-31 | 7.83% |
